Since 1999, this unique SRC has been a venue for disseminating progressive and contemporary scientific research on TGF-β signaling for academic and industrial scientists. This conference will explore the latest developments in this discipline, ranging from the molecular complexities of signal transduction to biological responses during development and adult tissue homeostasis in health and disease.
Since 1990, this essential conference has provided a platform for viral researchers to share their research, collaborate, and network to ensure a firm footing on which viral diseases and host defenses can be understood and novel therapeutics developed. The conference will cover topics and methodologies such as viral genomics, new anti-viral treatments, emerging viruses, and...
Since 2008, this FASEB Science Research Conference (SRC) has been the longest-running international conference dedicated exclusively to lipid droplet biology and its relevance to human disease. The sessions will explore lipid droplets in the context of their biogenesis/turnover, contacts with other organelles, integrative biology, and their role in human physiology and disease.
For over 35 years, this Science Research Conference (SRC) has presented and integrated advances in phospholipid biology and signaling to foster new national and international collaborative projects. This year’s SRC will continue to encourage and support junior investigators, trainees, women, and minority scientists to pursue phospholipid biology research, ensuring that the study of human diseases...
For over 30 years, this conference has brought together biomedical researchers and scientists that study protein lipidation, allowing those from different areas of specialization to come together and discuss new ideas and form synergistic collaborations. This year’s program will focus on a variety of disciplines within this field of study including mechanisms and consequences of...
Join FASEB for the sixth installment of this important conference, exploring GTPases in the fields of cytoskeleton, signaling, and membrane traffic. This year’s program will focus on how membrane structure and function are regulated, not just within molecular components, but regarding how they function. Recent findings indicate that there is an extensive crosstalk between membrane...
Leading CDMOs share their current available capacity - and associated capabilities, facility locations, and timelines - to help you identify options for your development and manufacturing needs. The final steps of pharmaceutical manufacturing, fill-finish processes, are paramount to product integrity. Our enhanced focus will introduce you to the latest sterile filling, lyophilization (freeze drying), and...
Leading CDMOs share their current available capacity - and associated capabilities, facility locations, and timelines - to help you identify options for your development and manufacturing needs. Dive into the biopharmaceutical realm, where the synthesis of biologically derived APIs encompasses cell line development, fermentation, and sophisticated purification techniques. The event will feature insights into process...
Leading CDMOs share their current available capacity - and associated capabilities, facility locations, and timelines - to help you identify options for your development and manufacturing needs. The cornerstone of effective treatments lies in the quality and reliability of API production. Our event will spotlight the state-of-the-art facilities and cutting-edge equipment driving the API manufacturing...
Leading CDMOs share their current available capacity - and associated capabilities, facility locations, and timelines - to help you identify options for your development and manufacturing needs. The journey from API to patient-ready products is intricate. Our updated content will cover the entire pharmaceutical product formulation, manufacturing, and packaging spectrum, emphasizing process development and GMP...
Sponsored by Thermo Fisher Scientific and PPD, experts will present innovative strategies in outsourcing discovery that allows small companies to focus on their core discovery needs and frees them up from both a capital and manpower investment.
Leading CDMOs share their current available capacity - and associated capabilities, facility locations, and timelines - to help you identify options for your development and manufacturing needs. Venture into the fast-developing areas of cell and gene therapy, covering a wide range of services from cell sourcing and expansion to vector design for gene therapy. This...
